探究肝癌介入治疗原发性中晚期肝癌的临床效果

Clinical Effect Study of Interventional Therapy for Primary Mid-term and Advanced Liver Cancer

目的本实验的课题主要探讨肝癌介入治疗在原发性中晚期肝癌患者的临床效果。方法对本院2013年2月至2018年2月所收治的60例原发性肝癌患者进行分组,30例对照组患者采用常规化疗治疗,30例实验组患者采用肝癌介入治疗,对比两组患者临床治疗效果与不良反应的发生情况。结果治疗后,实验组患者临床治疗的总有效率为90.00%,远高于对照组的63.33%,组间差异具有统计学意义(P<0.05);而在不良反应的发生情况中,实验组患者不良反应发生率远低于对照组,组间差异具有统计学意义(P<0.05)。结论肝癌介入治疗在原发性中晚期肝癌患者中具有良好的临床效果,能够有效提高患者治疗的有效率,值得临床广泛应用。

Objective to explore clinical effect of interventional therapy for primary mid term and advanced liver cancer in the study. Methods divide 60 cases primary liver cancer treated in our hospital from February 2013 to February 2018 into two groups, 30 cases in control group were treated with routine chemotherapy, and 30 cases in experimental group with interventional therapy for liver cancer. Compare curative effect and adverse reactions of two groups. Results after treatment, total effective rate of experimental group was 90.00%, much higher than 63.33% of control group. Difference was statistically significant between groups,（P〈0.05）. Adverse reactions incidence of experimental group was much lower than control group, difference was statistically significant between groups,（P〈0.05）. Conclusion interventional therapy for liver cancer has good clinical effect in treatment of patients with primary mid term and advanced liver cancer, can improve treatment effect effectively, which is worthy of wide clinical application.